Alvotech and Advanz announce EC approval for Gobivaz biosimilar
Gobivaz can treat juvenile idiopathic arthritis in children aged two and above when used with methotrexate.
Drug Development
Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership
Pfizer and Tris reach settlement with Texas over ADHD drug allegations
EC authorises Roche’s Lunsumio SC for follicular lymphoma
FDA approves AbbVie’s Epkinly to treat follicular lymphoma
Merus and Halozyme link on subcutaneous petosemtamab
Johnson & Johnson to acquire Halda Therapeutics for $3.05bn
BostonGene and Kyoto University link on oesophageal cancer drug
